
Omprakash Sitaram Saraf
About Omprakash Sitaram Saraf
Data last updated:
Omprakash Sitaram Saraf is a Director at Novus Remedies Private Limited (since 2022) and Director at Novus Pharmaceuticals Limited (since 1995). The companies operate in Environment and Pharma. The largest current company by reported revenue is Novus Remedies Private Limited at ₹2.13 Cr (FY 2024).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 10 Dec 2022 | 2008 | ₹2.13 Cr (FY 2024) | Active | |
| Director | 26 Jun 1995 | 1995 | Active |
Board colleagues of Omprakash Sitaram Saraf
| Name | DIN | Company | Designation |
|---|---|---|---|
| Ashish Omprakash Saraf | 02219056 | Novus Remedies Private Limited | Director |
| Vijay Balasaheb Shinde | 10449931 | Novus Remedies Private Limited | Additional Director |
| Pramod Sitaram Saraf | 01727027 | Novus Pharmaceuticals Limited | Director |
| Subhashchandra Khetaram Choudhary | 05173670 | Novus Pharmaceuticals Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Omprakash Sitaram Saraf
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Omprakash Sitaram Saraf
Omprakash Sitaram Saraf currently holds 2 directorships: Novus Remedies Private Limited (Director, since 10 Dec 2022, revenue ₹2.13 Cr (FY 2024)); Novus Pharmaceuticals Limited (Director, since 26 Jun 1995).
Omprakash Sitaram Saraf was first appointed on 26 Jun 1995 as Director at Novus Pharmaceuticals Limited. The most recent appointment on record is 10 Dec 2022 at Novus Remedies Private Limited.
The current boards of Omprakash Sitaram Saraf's companies include Ashish Omprakash Saraf (Novus Remedies Private Limited), Vijay Balasaheb Shinde (Novus Remedies Private Limited), Pramod Sitaram Saraf (Novus Pharmaceuticals Limited), Subhashchandra Khetaram Choudhary (Novus Pharmaceuticals Limited).